Novanta Inc. (NOVT) Earnings Call Analysis

NASDAQ · Technology · Scientific & Technical Instruments

23/25

Growth 5 Margin 5 Expansion 5 Platform 3 Financial 5

latest quarter score

Earnings Reports

23
Novanta (NOVT) Q2 2026: Riverpoint Medical Adds $65M, Elevates Recurring Revenue to 25%
August 06, 2026
22
NOVT Q1 2026: Bookings Surge 37% as GenAI and Medical Consumables Fuel Multi-Segment Upside
May 12, 2026
21
Novanta (NOVT) Q4 2025: Bookings Surge 25% as Backlog and New Product Revenue Hit Record Highs
February 25, 2026
23
Novanta (NOVT) Q3 2025: New Product Revenue Surges 60%, Securing Growth Platform Momentum
November 04, 2025
19
Novanta (NOVT) Q2 2025: Bookings Jump 10% as Design Wins Accelerate Physical AI and Medtech Pipeline
August 05, 2025
22
Novanta (NOVT) Q2 2025: New Product Revenue Surges 50%, Securing Growth in Robotics and Surgery
August 05, 2025
22
Novanta (NOVT) Q1 2025: $20M Tariff Cost Hits Spark Aggressive Supply Chain Pivot
July 07, 2025

Browse all companies